{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:47:55Z","timestamp":1794473275781,"version":"4.9.1"},"reference-count":63,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ceva Innovation Center GmbH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>(1) Background: The oral vaccination of free-roaming dogs against rabies has been developed as a promising complementary tool for mass dog vaccination. However, no oral rabies vaccine has provided efficacy data in dogs according to international standards. (2) Methods: To test the immunogenicity and efficacy of the third-generation oral rabies virus vaccine strain, SPBN GASGAS, in domestic dogs, dogs were offered an egg-flavoured bait containing 3.0 mL of the vaccine (107.5 FFU\/mL) or a placebo egg-flavoured bait. Subsequently, these 25 vaccinated and 10 control animals were challenged approximately 6 months later with a dog rabies virus isolate. Blood samples were collected at different time points postvaccination and examined by ELISA and RFFIT. (3) Results: All but 1 of the 25 vaccinated dogs survived the challenge infection; meanwhile, all 10 control dogs succumbed to rabies. The serology results showed that all 25 vaccinated dogs seroconverted in ELISA (&gt;40% PB); meanwhile, only 13 of the 25 vaccinated dogs tested seropositive \u2265 0.5 IU\/mL) in RFFIT. (4) Conclusions: The SPBN GASGAS rabies virus vaccine meets the efficacy requirements for live oral rabies vaccines as laid down by the European Pharmacopoeia and the WOAH Terrestrial Manual. SPBN GASGAS already fulfilled the safety requirements for oral rabies vaccines targeted at dogs. Hence, the egg-flavoured bait containing SPBN GASGAS is the first oral vaccine bait that complies with WOAH recommendations for the intended use of oral vaccination of free-roaming dogs against rabies.<\/jats:p>","DOI":"10.3390\/vaccines11020307","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T08:28:23Z","timestamp":1675067303000},"page":"307","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Efficacy of Oral Rabies Vaccine Baits Containing SPBN GASGAS in Domestic Dogs According to International Standards"],"prefix":"10.3390","volume":"11","author":[{"given":"Katharina","family":"Bobe","sequence":"first","affiliation":[{"name":"Ceva Innovation Center, Am Pharmapark, (D.P.-B. formerly: Institute of Epidemiology, Friedrich-Loeffler-Institute), 06861 Dessau-Rosslau, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Ortmann","sequence":"additional","affiliation":[{"name":"Ceva Innovation Center, Am Pharmapark, (D.P.-B. formerly: Institute of Epidemiology, Friedrich-Loeffler-Institute), 06861 Dessau-Rosslau, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kaiser","sequence":"additional","affiliation":[{"name":"TEW Servicegesellschaft GmbH, Am Pharmapark, (C.K. formerly: Ceva Innovation Center), 06861 Dessau-Rosslau, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Perez-Bravo","sequence":"additional","affiliation":[{"name":"Ceva Innovation Center, Am Pharmapark, (D.P.-B. formerly: Institute of Epidemiology, Friedrich-Loeffler-Institute), 06861 Dessau-Rosslau, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7455-803X","authenticated-orcid":false,"given":"J\u00f6rn","family":"Gethmann","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology, Friedrich-Loeffler-Institute, 17493 Greifswald-Insel Riems, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Kliemt","sequence":"additional","affiliation":[{"name":"Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institute, 17493 Greifswald-Insel Riems, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"K\u00f6rner","sequence":"additional","affiliation":[{"name":"Ceva Innovation Center, Am Pharmapark, (D.P.-B. formerly: Institute of Epidemiology, Friedrich-Loeffler-Institute), 06861 Dessau-Rosslau, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Theu\u00df","sequence":"additional","affiliation":[{"name":"Ceva Innovation Center, Am Pharmapark, (D.P.-B. formerly: Institute of Epidemiology, Friedrich-Loeffler-Institute), 06861 Dessau-Rosslau, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lindner","sequence":"additional","affiliation":[{"name":"Ceva Innovation Center, Am Pharmapark, (D.P.-B. formerly: Institute of Epidemiology, Friedrich-Loeffler-Institute), 06861 Dessau-Rosslau, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1076-398X","authenticated-orcid":false,"given":"Conrad","family":"Freuling","sequence":"additional","affiliation":[{"name":"Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institute, 17493 Greifswald-Insel Riems, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0959-3653","authenticated-orcid":false,"given":"Thomas","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institute, 17493 Greifswald-Insel Riems, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad","family":"Vos","sequence":"additional","affiliation":[{"name":"Ceva Innovation Center, Am Pharmapark, (D.P.-B. formerly: Institute of Epidemiology, Friedrich-Loeffler-Institute), 06861 Dessau-Rosslau, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Slate, D., Algeo, T.P., Nelson, K.M., Chipman, R.B., Donovan, D., Blanton, J.D., Niezgoda, M., and Rupprecht, C.E. (2009). Oral Rabies Vaccination in North America: Opportunities, Complexities, and Challenges. PLoS Negl. Trop. Dis., 3.","DOI":"10.1371\/journal.pntd.0000549"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"20120142","DOI":"10.1098\/rstb.2012.0142","article-title":"The elimination of fox rabies from Europe: Determinants of success and lessons for the future","volume":"368","author":"Freuling","year":"2013","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_3","first-page":"133","article-title":"Rabies vaccination programme for red foxes (Vulpes vulpes) and golden jackals (Canis aureus) in Israel (1999-2004)","volume":"125","author":"Yakobson","year":"2006","journal-title":"Dev. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.7774\/cevr.2019.8.2.132","article-title":"Rabies immune status of raccoon dogs residing in areas where rabies bait vaccine has been distributed","volume":"8","author":"Yang","year":"2019","journal-title":"Clin. Exp. Vaccine Res."},{"key":"ref_5","unstructured":"WHO (2018). WHO Expert Consultation on Rabies, Third Report."},{"key":"ref_6","unstructured":"WHO (1988). Report of WHO Consultation on Oral Immunization of Dogs against Rabies, Geneva, 26\u201327 February 1988, WHO\/Rab.Res\/88.26."},{"key":"ref_7","unstructured":"WHO (1991). 2nd WHO Consultation on Oral Immunization of Dogs against Rabies, Geneva, 6 July 1990, WHO\/Rab.Res.\/91.37."},{"key":"ref_8","unstructured":"WHO (1992). 3rd [Third] Consultation on Oral Immunization of Dogs against Rabies, Geneva, 21\u201322 July 1992\/Organized by WHO with the Participation of the Office International des \u00c9pizooties, WHO\/Rab.Res.\/92.38."},{"key":"ref_9","unstructured":"WHO (1993). Report of the Fourth WHO Consultation on Oral Immunization of Dogs against Rabies, Geneva, 14\u201315 June 1993, WHO\/Rab.Res.\/93.42."},{"key":"ref_10","unstructured":"WHO (1994). Report of the Fifth Consultation on Oral Immunization of Dogs against Rabies, Geneva, 20\u201322 June 1994, WHO\/Rab.Res.\/94.45."},{"key":"ref_11","unstructured":"WHO (1998). Oral Immunization of Dogs against Rabies: Report of the Sixth WHO Consultation, Geneva, 24\u201325 July 1995, WHO\/EMC\/ZDI\/98.13."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid2612.201266","article-title":"Role of oral rabies vaccines in the elimination of dog-mediated human rabies deaths","volume":"26","author":"Wallace","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e780","DOI":"10.1016\/S2214-109X(16)30245-5","article-title":"The beginning of the end of rabies?","volume":"4","author":"Knopf","year":"2016","journal-title":"Lancet Glob Health."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13567-018-0554-6","article-title":"Oral vaccination of dogs: A well-studied and undervalued tool for achieving human and dog rabies elimination","volume":"49","author":"Cliquet","year":"2018","journal-title":"Vet Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yale, G., Lopes, M., Isloor, S., Head, J.R., Mazeri, S., Gamble, L., Dukpa, K., Gongal, G., and Gibson, A.D. (2022). Review of Oral Rabies Vaccination of Dogs and Its Application in India. Viruses, 14.","DOI":"10.3390\/v14010155"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"A77","DOI":"10.1016\/j.vaccine.2019.01.015","article-title":"Priorities in applied research to ensure programmatic success in the global elimination of canine rabies","volume":"37","author":"Rupprecht","year":"2019","journal-title":"Vaccine"},{"key":"ref_17","first-page":"5","article-title":"Oral Rabies Vaccines: A boon in control of rabies in free ranging dogs in India","volume":"23","author":"Varughese","year":"2022","journal-title":"Assoc. Prev. Control. Rabies India J."},{"key":"ref_18","unstructured":"Council of Europe (2019). European Pharmacopoeia 10.0, EDQM."},{"key":"ref_19","unstructured":"OIE (2018). Terrestrial Manual Chapter 3.1.18 Rabies (Infection with Rabies Virus and Other Lyssaviruses), OIE. Available online: https:\/\/www.woah.org\/fileadmin\/Home\/eng\/Health_standards\/tahm\/3.01.18_RABIES.pdf."},{"key":"ref_20","first-page":"74","article-title":"Efficacy of oral rabies vaccine baits in indigenous Turkish dogs","volume":"2","author":"Aylan","year":"2000","journal-title":"Infect. Dis. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1016\/j.vaccine.2006.12.054","article-title":"The safety and efficacy of the oral rabies vaccine SAG2 in Indian stray dogs","volume":"25","author":"Cliquet","year":"2007","journal-title":"Vaccine"},{"key":"ref_22","first-page":"257","article-title":"Vaccine Efficacy of a square presentation of V-RG vaccine baits in red fox, domestic dog and raccoon dog","volume":"131","author":"Cliquet","year":"2008","journal-title":"Dev. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1007\/s00705-017-3499-6","article-title":"Protective immune response of oral rabies vaccine in stray dogs, corsacs and steppe wolves after a single immunization","volume":"162","author":"Zhugunissov","year":"2017","journal-title":"Arch. Virol."},{"key":"ref_24","first-page":"607","article-title":"Vaccination of Tunisian dogs with the lyophilised SAG2 oral rabies vaccine incorporated into the DBL2 dog bait","volume":"30","author":"Hammami","year":"1999","journal-title":"Vet. Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Vos, A., Nokireki, T., Isomaursu, M., Gadd, T., and Kovacs, F. (2021). Oral vaccination of foxes and raccoon dogs against rabies with the 3rd generation oral rabies virus vaccine, SPBN GASGAS, in Finland. BMC Acta Vet. Scand., 63.","DOI":"10.1186\/s13028-021-00605-y"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1016\/j.vaccine.2017.09.096","article-title":"Evaluation of Immune Responses in Dogs to Oral Rabies Vaccine under Field Conditions","volume":"37","author":"Smith","year":"2019","journal-title":"Vaccine"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Chanachai, K., Wongphruksasoong, V., Vos, A., Leelahapongsathon, K., Tangwangvivat, R., Sagarasaeranee, O., Lekcharoen, P., Trinuson, P., and Kasemsuwan, S. (2021). Feasibility and Effectiveness Studies with Oral Vaccination of Free-Roaming Dogs against Rabies in Thailand. Viruses, 13.","DOI":"10.3390\/v13040571"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"737250","DOI":"10.3389\/fvets.2021.737250","article-title":"Immunogenicity of the oral rabies vaccine strain SPBN GASGAS in dogs under field settings in Namibia","volume":"8","author":"Molini","year":"2021","journal-title":"Front. Vet. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Freuling, C.M., Busch, F., Vos, A., Ortmann, S., Lohr, F., Hedimbi, N., Josephat, P., Nelson, H.A., Shoombe, K., and Shilongo, A. (2022). Oral vaccination of dogs\u2014experiences from a field trial in Namibia. PLoS Negl. Trop. Dis., 16.","DOI":"10.1101\/2022.04.21.488865"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Leelahapongsathon, K., Kasemsuwan, S., Pinyopummintr, T., Boodde, O., Phawaphutayanchai, P., Aiyara, N., Bobe, K., Vos, A., Friedrichs, V., and M\u00fcller, T. (2020). Humoral immune response of Thai dogs after oral vaccination against rabies with the SPBN GASGAS vaccine strain. Vaccines, 8.","DOI":"10.3390\/vaccines8040573"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1863-2378.2008.01215.x","article-title":"Immunogenicity and safety of recombinant rabies viruses used for oral vaccination of stray dogs and wildlife","volume":"56","author":"Faber","year":"2009","journal-title":"Zoonoses Public Health"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"14141","DOI":"10.1128\/JVI.79.22.14141-14148.2005","article-title":"A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity","volume":"79","author":"Faber","year":"2005","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1128\/JVI.76.7.3374-3381.2002","article-title":"Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response","volume":"76","author":"Faber","year":"2002","journal-title":"J. Virol."},{"key":"ref_34","first-page":"912","article-title":"Case report: Rabies in a vaccinated dog imported from Azerbaijan","volume":"84","author":"Weber","year":"2003","journal-title":"Der Prakt. Tierarzt"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"23887","DOI":"10.1038\/srep23887","article-title":"Reverse genetics in high throughput. rapid generation of complete negative strand RNA virus cDNA clones and recombinant viruses thereof","volume":"6","author":"Nolden","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_36","first-page":"227","article-title":"The Method of \u201cRight and Wrong Cases\u201d (Constant Stimuli) without Gauss\u2019s Formula","volume":"2","author":"Spearman","year":"1908","journal-title":"Br. J. Psychol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche","volume":"162","year":"1931","journal-title":"Arch. Exp. Path. Pharmakol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1016\/j.vaccine.2017.09.093","article-title":"Efficacy of the oral rabies virus vaccine strain SPBN GASGAS in foxes and raccoon dogs","volume":"37","author":"Freuling","year":"2019","journal-title":"Vaccine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jviromet.2012.11.022","article-title":"Evaluation of an ELISA to detect rabies antibodies in orally vaccinated foxes and raccoon dogs sampled in the field","volume":"187","author":"Wasniewski","year":"2013","journal-title":"J. Virol. Methods"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jviromet.2011.10.019","article-title":"Evaluation of ELISA for detection of rabies antibodies in domestic carnivores","volume":"179","author":"Wasniewski","year":"2012","journal-title":"J. Virol. Methods"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Moore, S., Gilbert, A., Vos, A., Freuling, C., Ellis, C., Kliemt, J., and M\u00fcller, T. (2017). Review of rabies virus antibodies from oral vaccination as a correlate of protection against lethal infection in animals. Trop. Med. Infect. Dis., 2.","DOI":"10.3390\/tropicalmed2030031"},{"key":"ref_42","unstructured":"R Core Team (2020). R: A language and Environment for Statistical Computing, R Foundation for Statistical Computing."},{"key":"ref_43","unstructured":"Grothendieck, G. (2022, October 12). nls2: Non-Linear Regression with Brute Force. R Package Version 0.3\u20133. Available online: https:\/\/CRAN.R-project.org\/package=nls2."},{"key":"ref_44","first-page":"195","article-title":"Cross reactive antigenicity in orally vaccinated foxes and raccoon dogs against European Bat Lyssavirus type 1 and 2","volume":"125","author":"Selhorst","year":"2006","journal-title":"Dev. Biol."},{"key":"ref_45","unstructured":"Meslin, F.X., Kaplan, M.M., and Koprowski, H. (1996). The fluorescence antibody test, Laboratory Techniques in Rabies."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1128\/JCM.00612-10","article-title":"Improved safety for molecular diagnosis of classical rabies viruses by use of a TaqMan real-time reverse transcription-PCR \u201cdouble check\u201d strategy","volume":"48","author":"Hoffmann","year":"2010","journal-title":"Clin. Microbiol."},{"key":"ref_47","unstructured":"Meslin, F.X., Kaplan, M.M., and Koprowski, H. (1996). Virus isolation in neuroblastoma cell culture, Laboratory Techniques in Rabies."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Moore, S.M., and Hanlon, C.A. (2010). Rabies-Specific Antibodies. Measuring Surrogates of Protection against a Fatal Disease. PLoS Negl. Trop. Dis., 4.","DOI":"10.1371\/journal.pntd.0000595"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1017\/S095026880500381X","article-title":"Comparative evaluation of specific ELISA and RFFIT antibody assays in the assessment of dog immunity against rabies","volume":"133","author":"Bahloul","year":"2005","journal-title":"Epidemiol. Infect."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1017\/S0950268899002563","article-title":"A rabies serosurvey of domestic dogs in rural Tanzania: Results of a rapid fluorescent focus inhibition test (RFFIT) and a liquid-phase blocking ELISA used in parallel","volume":"123","author":"Cleaveland","year":"1999","journal-title":"Epidemiol. Infect."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1016\/S0264-410X(03)00102-6","article-title":"Standardisation and establishment of a rabies ELISA test in European laboratories for assessing the efficacy of oral fox vaccination campaigns","volume":"21","author":"Cliquet","year":"2003","journal-title":"Vaccine"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Freuling, C.M., Te Kamp, V., Klein, A., G\u00fcnther, M., Zaeck, L., Potratz, M., Eggerbauer, E., Bobe, K., Kaiser, C., and Kretzschmar, A. (2019). Long-term immunogenicity and efficacy of the oral rabies virus vaccine strain SPBN GASGAS in foxes. Viruses, 11.","DOI":"10.3390\/v11090790"},{"key":"ref_53","first-page":"39","article-title":"Duration of immunity in foxes vaccinated orally with ERA vaccine in a bait","volume":"61","author":"Lawson","year":"1997","journal-title":"Can. J. Vet. Res."},{"key":"ref_54","unstructured":"WOAH (2022). Terrestrial Animal Health Code, World Organization for Animal Health."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fvets.2018.00091","article-title":"In Vivo Safety Studies With SPBN GASGAS in the Frame of Oral Vaccination of Foxes and Raccoon Dogs Against Rabies","volume":"5","author":"Ortmann","year":"2018","journal-title":"Front. Vet. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.vaccine.2017.12.076","article-title":"An assessment of shedding with the oral rabies virus vaccine strain SPBN GASGAS in target and non-target species","volume":"36","author":"Vos","year":"2018","journal-title":"Vaccine"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1038\/s41598-019-42714-9","article-title":"Environmental distribution of certain modified live-virus vaccines with a high safety profile presents a low-risk, high-reward to control zoonotic diseases","volume":"9","author":"Head","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Borutzki, S., Richter, B., Proemmel, M., Fabianska, I., Tran, Q.H., Hundt, B., Mayer, D., Kaiser, C., Neubert, A., and Vos, A. (2022). Oral rabies vaccine strain SPBN GASGAS; genetic stability after serial in vitro and in vivo passaging. Viruses, 14.","DOI":"10.3390\/v14102136"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Estrada, R.Q., Vos, A.C., and De Leon, R.C. (2001). Acceptability of local-made baits for oral vaccination of dogs against rabies in the Philippines. BMC Infect. Dis., 1.","DOI":"10.1186\/1471-2334-1-19"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Estrada, R.Q., Vos, A.C., De Leon, R.C., and M\u00fcller, T. (2001). Field trial with oral vaccination of dogs against rabies in the Philippines. BMC Infect. Dis., 1.","DOI":"10.1186\/1471-2334-1-23"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Bender, S., Bergman, D., Vos, A., Martin, A., and Chipman, R. (2017). Field studies evaluating bait acceptance and handling by dogs in Navajo Nation, USA. Trop. Med. Infect. Dis., 2.","DOI":"10.3390\/tropicalmed2020017"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Kasemsuwan, S., Chanachai, K., Pinyopummintr, T., Leelalapongsathon, K., Sujit, K., and Vos, A. (2018). Field studies evaluating bait acceptance and -handling by free-roaming dogs in Thailand. Front. Vet. Sci., 5.","DOI":"10.3390\/vetsci5020047"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Langguth, A., Leelahapongsathon, K., Wannapong, N., Kasemsuwan, S., Ortmann, S., Vos, A., and B\u00f6er, M. (2021). Comparative Study of Optical Markers to assess Bait System Efficiency concerning Vaccine Release in the Oral Cavity of Dogs. Viruses, 13.","DOI":"10.3390\/v13071382"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/2\/307\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:20:13Z","timestamp":1760120413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/2\/307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["vaccines11020307"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11020307","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,30]]}}}